Trifluoroacetic acid → Ethyl 4-(2-oxo-1,4-dihydropyrido[3,4-d]pyrimidin-3(2H)-yl)piperidine-1-carboxylate

HRID 967526

反応式

HRID 967526 の反応式
FC(F)(F)C(O)=O.C([O:12][C:13]([NH:15][C:16]1[CH:17]=[N:18][CH:19]=[CH:20][C:21]=1[CH2:22][NH:23][CH:24]1[CH2:29][CH2:28][N:27]([C:30]([O:32][CH2:33][CH3:34])=[O:31])[CH2:26][CH2:25]1)=O)(C)(C)C.C(N1C=CN=C1)(N1C=CN=C1)=O>ClCCl>[O:12]=[C:13]1[NH:15][C:16]2[CH:17]=[N:18][CH:19]=[CH:20][C:21]=2[CH2:22][N:23]1[CH:24]1[CH2:29][CH2:28][N:27]([C:30]([O:32][CH2:33][CH3:34])=[O:31])[CH2:26][CH2:25]1

参加物

5

実験手順

Trifluoroacetic acid (1.43 g) was added to a solution of the material from Step A (0.47 g, 1.24 mmol) in dichloromethane (10 mL). After stirring overnight, the reaction was concentrated. This material was dissolved in acetonitrile (5 mL) and carbonyldiimidazole (0.62 g, 3.73 mmol) was added at room temperature. After 2 d, the acetonitrile was evaporated in vacuo, the residue partitioned between 1N NaOH and dichloromethane, and the organic phase dried over magnesium sulfate. The crude product was purified by chromatography (silica gel, 1 to 20% methanol in methylene chloride gradient elution), which gave the title compound (0.15 g). MS 305.2.

後処理

  1. concentrationthe reaction was concentrated
  2. dissolutionThis material was dissolved in acetonitrile (5 mL)
  3. waitAfter 2 d
  4. customthe acetonitrile was evaporated in vacuo
  5. customthe residue partitioned between 1N NaOH and dichloromethane
  6. dry with materialthe organic phase dried over magnesium sulfate
  7. customThe crude product was purified by chromatography (silica gel, 1 to 20% methanol in methylene chloride gradient elution), which

出典と根拠

ORDレコード
ord-bfe061e3aa224b6f9e7e9eedd2927591
出典データセット
uspto-grants-2005_10
特許番号
US06953790B2

関連ノート

読み込み中…